Christoph Gerlinger

9PUBLICATIONS
32CO-AUTHORS
Autonomic nervous systemPharmacogenomicsAllergyMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 27, 2026
Optimizing NT-proBNP Inclusion Cut-offs for Randomized Clinical Trials in Heart Failure: Data from the Swedish Heart Failure Registry.

Megan Schroeder, Lars H Lund, Christoph Gerlinger

|Feb 20, 2025
Decision-Making Criteria and Methods for Initiating Late-Stage Clinical Trials in Drug Development From a Multi-Stakeholder Perspective: A Scoping Review.

Ce Jiang, Céline Beji, Sonia Zebachi

|Sep 23, 2024
Does the risk of hypersensitivity reactions to iopromide differ by sex, race, or across regions/countries? An analysis of 152 233 patients from 4 observational studies and the company's pharmacovigilance database.

Jan Endrikat, Alexander Ullmann, Christoph Gerlinger

|Jun 27, 2024
Developing a fit-for-purpose composite symptom score as a symptom burden endpoint for clinical trials in patients with malignant pleural mesothelioma.

Charles S Cleeland, Karen N Keating, Brian Cuffel

|Sep 09, 2023
Accuracy of Breast Ultrasonography and Mammography in Comparison with Postoperative Histopathology in Breast Cancer Patients after Neoadjuvant Chemotherapy.

Gilda Schmidt, Sebastian Findeklee, Gerda Del Sol Martinez

|Jul 27, 2022
Postpartum Assessment of the Correlation between Serum Hormone Levels of Estradiol, Progesterone, Prolactin and ß-HCG and Blood Pressure Measurements in Pre-Eclampsia Patients.

Mariz Kasoha, Zoltan Takacs, Jacob Dumé

Pageof 2

Frequent Collaborators

2 joint publications

Sebastian Findeklee

1 joint publications

Jeremy Rassen

1 joint publications

Romina-Marina Sima

1 joint publications

Mihai-Teodor Georgescu